Where our team of editors discuss what they think about the current NGP US Issues.
Karen Gotting-Smith tells NGP how AstraZeneca stays fighting fit in difficult times.
Next generation DNA sequencing instruments, introduced to the market in the past few years, are beginning to dominate the landscape of DNA sequencing projects – and rightfully so.
Collaboration is more than just working together on shared documents. Collaboration is a fundamental aspect of the business that is present throughout the modern pharmaceutical organization. As companies transition to more distributed operations, and
The life sciences industry continues to be challenged by the competing demands of regulatory drivers, distribution requirements and changing patient demographics.
The biopharmaceutical industry is depending increasingly on outsourcing services. The advantages of outsourcing have proven them self in a diverse range of industries and can be a driver for improving both financial as well as operating performance. By QMR Technology